Literature DB >> 31143991

Reply to "Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis" by S. Noe, H. Jaeger, E. Wolf.

E Biver1, A Calmy2, C Meier3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31143991     DOI： 10.1007/s00198-019-05025-3

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  2 in total

1.  Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis : Comment on "Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis".

Authors:  S Noe; H Jaeger; E Wolf
Journal:  Osteoporos Int       Date:  2019-05-29       Impact factor: 4.507

2.  Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.

Authors:  E Biver; A Calmy; B Aubry-Rozier; M Birkhäuser; H A Bischoff-Ferrari; S Ferrari; D Frey; R W Kressig; O Lamy; K Lippuner; N Suhm; C Meier
Journal:  Osteoporos Int       Date:  2019-01-02       Impact factor: 4.507
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.